Meritage Group’s Colgate-Palmolive CL Stock Holding History

Meritage Group’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-18,699	Closed	-$1.22M	–	32
2016 Q4	$1.22M	Buy	+18,699	New	+$1.28M	0.03%	65

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Meritage Group's CL Position: Q1 2017 in Review

Meritage Group sold out of Colgate-Palmolive (CL) in Q1 2017, closing a stake of 18,699 shares — an estimated $1.22M sold.

Meritage Group first reported a position in CL in Q4 2016 and held it in 1 quarter. The position peaked at $1.22M in Q4 2016. 1,365 funds tracked by Wall St. Rank hold CL as of Q1 2017.

Meritage Group reported no remaining Colgate-Palmolive position as of Q1 2017 after selling out during the quarter.
Meritage Group sold 18,699 Colgate-Palmolive shares in Q1 2017, an estimated $1.22M.
Meritage Group first reported a position in Colgate-Palmolive in Q4 2016 and held it in 1 quarter.
Meritage Group's Colgate-Palmolive position peaked at $1.22M in Q4 2016.
1,365 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2017.

Based on Meritage Group's 13F filing for Q1 2017, filed 12 May 2017.